Skip Navigation Links

Current Metabolomic Biomarker Projects


  • Exploratory Study to Analyze Variations in Metabolite Levels, D- and L-isomers of 2-hydroxyglutaric acid in Acute Myeloid Leukemia Patients with IDH Mutations
  • Metabolomic Salivary Biomarkers for Oral Cancer Detection
  • Methionine metabolism in esophageal adenocarcinoma carcinogenesis



Vascular Disease

  • A targeted metabolic study to investigate blood methylation biomarkers in patients with coronary artery disease
  • Urinary metabolomic study using the Biocrate P180 kit in patients with coronary artery disease
  • Clinical Outcomes and Metabolomic and Damage Associated Molecular Patterns of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention via the Radial versus Femoral Artery Approach



Central Nervous System

  • One-Carbon Metabolism Markers in Post Traumatic Epilepsy
  • A Double-Blind, Controlled, Randomized Clinical Trial of the Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants
  • Plasma and Cerebrospinal fluid methylation metabolome in mild cognitive impairment and Alzheimer's disease
  • Plasma metabolomic study using the Biocrate P180 kit to investigate biomarkers of anti-depressant therapy




  • Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
  • The Reproductive Microbiome & Perinatal Health Outcomes: Improving the Lives of Mothers & Babies

Copyright © 2019 Baylor Scott & White Health All Rights Reserved.   |   3500 Gaston Avenue, Dallas, TX 75246-2017   |   1.800.9BAYLOR
Site Map   |   Privacy Terms & Patient Rights   |   Terms of Use